Teleflex Incorporated ($TFX) Stock Forecast: Up 5.3% Today

What is Teleflex Incorporated?

Teleflex Incorporated (TFX) operates in the medical devices sector focusing on critical care and surgical equipment. The company is recognized for its inventive healthcare solutions and diverse product range.

Why is Teleflex Incorporated going up?

TFX stock is up 5.3% on Nov 1, 2024 15:45

• TFX displayed a robust bullish trend today despite revising its 2024 revenue forecast downwards.
• Exceeding Q3 earnings projections and declaring a quarterly dividend likely bolstered investor confidence in the company's stock.
• The introduction of new vascular access products in Canada may have indicated growth prospects for TFX, playing a role in the positive market performance.
• The stock's upward movement seems influenced by favorable earnings results and strategic product introductions, potentially overshadowing concerns about the reduced revenue expectations.

TFX Price Chart

TFX Technical Analysis

TFX News

Teleflex Q3 Earnings Top, Stock Falls on Lowered 2024 Revenue Outlook

TFX benefits from a diversified product portfolio in the third quarter of 2024, with strength in the Vascular Access and Interventional segments.

https://www.zacks.com/stock/news/2362326/teleflex-q3-earnings-top-stock-falls-on-lowered-2024-revenue-outlook

Teleflex ( TFX ) Surpasses Q3 Earnings Estimates

Teleflex (TFX) delivered earnings and revenue surprises of 3.25% and 0.43%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2361431/teleflex-tfx-surpasses-q3-earnings-estimates

Teleflex Announces Quarterly Dividend - Teleflex ( NYSE:TFX )

WAYNE, Pa., Oct. 31, 2024 ( GLOBE NEWSWIRE ) -- Teleflex Incorporated TFX announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ( $0.34 ) per share of common stock. The dividend is payable December 16, 2024, to shareholders of record at the close of ...

https://www.benzinga.com/pressreleases/24/10/g41648312/teleflex-announces-quarterly-dividend

TFX Stock to Gain From Launch of New Vascular Access Devices in Canada

Teleflex launches the next-generation Arrow VPS Rhythm DLX Device and NaviCurve Stylet in Canada.

https://www.zacks.com/stock/news/2358401/tfx-stock-to-gain-from-launch-of-new-vascular-access-devices-in-canada

Trending Today

Memecoin ($MEME) Crypto Forecast: Up 6.0% Today

TRON ($TRX) Crypto Forecast: Up 7.0% Today

Cardano ($ADA) Crypto Forecast: Up 11.4% Today

Dogecoin ($DOGE) Crypto Forecast: Up 9.8% Today

Toncoin ($TON) Crypto Forecast: Up 16.0% Today

The Graph ($GRT) Crypto Forecast: Up 17.6% Today

Shiba Inu ($SHIB) Crypto Forecast: Up 9.2% Today

VeChain ($VET) Crypto Forecast: Up 36.3% Today

POL (Polygon) ($POL) Crypto Forecast: Up 27.3% Today

Binance Coin ($BNB) Crypto Forecast: Up 8.3% Today

Teleflex Incorporated Price History

25.08.2024 - TFX Stock was up 0.7%

• Comparisons with EW indicate that TFX might be the better value option at the moment.
• Optimism about TFX's performance in the Interventional category and its potential in Asia has positively influenced investors.
• This optimism and potential value could be factors behind the bullish movement in TFX's stock today.

01.10.2024 - TFX Stock was up 5.3%

• TFX displayed a robust bullish trend today despite revising its 2024 revenue forecast downwards.
• Exceeding Q3 earnings projections and declaring a quarterly dividend likely bolstered investor confidence in the company's stock.
• The introduction of new vascular access products in Canada may have indicated growth prospects for TFX, playing a role in the positive market performance.
• The stock's upward movement seems influenced by favorable earnings results and strategic product introductions, potentially overshadowing concerns about the reduced revenue expectations.

31.09.2024 - TFX Stock was down 15.8%

• Despite surpassing Q3 earnings estimates, Teleflex saw a decline in its stock price.
• The company's announcement of a quarterly dividend is typically a show of confidence in its financial standing, yet it was not enough to counteract the bearish trend.
• The introduction of new vascular access devices in Canada may have been a positive move, but other factors appear to have influenced the stock's decline.
• Investor response to general market conditions or industry-specific challenges could be contributing to the downward trend in TFX stock, despite positive developments.

14.05.2023 - TFX Stock was up 4.4%

• TFX had a strong bullish movement today.
• The FDA approval of TFX's Arrow EZ-IO Needle and Wattson Temporary Pacing Guidewire may have contributed to the bullish movement.
• The selling of TFX shares by Teacher Retirement System of Texas did not have a significant impact on the market movement.

22.01.2024 - TFX Stock was down 5.3%

• Despite exceeding earnings and revenue expectations and providing positive guidance, the stock saw a decline.
• The decrease in Q4 profit, despite surpassing estimates, may have influenced market sentiment negatively.
• Concerns may arise regarding the company's dividend sustainability, as the quarterly dividend was set at 34 cents a share.
• The upcoming conference call scheduled for February 22 to review quarterly and annual financial results could offer additional insights into the company's performance and future prospects, potentially impacting the stock further.

02.10.2023 - TFX Stock was up 9.1%

• Teleflex reported higher net income and revenue for the third quarter, beating estimates.
• The company announced a quarterly cash dividend, indicating confidence in its financial performance.
• The positive earnings report and dividend announcement likely contributed to the bullish market movement for TFX.
• Investors may have been pleased with the company's performance and optimistic about its future growth prospects.

03.05.2024 - TFX Stock was up 3.3%

• The successful commercialization of Teleflex's UroLift in Japan is boosting market share, highlighting strong potential for revenue growth.
• The expansion of this therapy for men with BPH (Benign Prostatic Hyperplasia) presents promising market opportunities for Teleflex, bolstering investor confidence and a bullish trend in the stock.
• Despite macroeconomic challenges like global economic uncertainties, Teleflex's strategic progress in the healthcare sector is outshining these concerns and fueling the bullish market movement of TFX.

04.04.2023 - TFX Stock was down 7.1%

• Today, TFX had a strong bearish movement. Here's why:
• TFX reported a decline in Q1 income, missing the Street estimates, which could have led to a negative sentiment among investors.
• However, TFX beat Q1 top and bottom line estimates and updated its FY23 outlook, which could have provided some support to the stock.
• The news about the UroLift® System facilitating long-term outcomes for BPH patients might not have had a significant impact on TFX's stock movement.
• Overall, the mixed earnings report and guidance update could have been the main drivers of TFX's bearish movement today.

18.06.2024 - TFX Stock was down 5.6%

• The downtrend in TFX stock could be linked to investor speculation about the upcoming second-quarter financial results conference call.
• There appears to be investor hesitancy or doubt regarding the operational update that will be provided during the call, resulting in a sell-off of TFX shares.
• Market participants may be responding to potential guidance or performance clues teased in the announcement, prompting some investors to proceed with caution and sell their Teleflex Incorporated holdings.
• Some investors may have been anticipating more positive developments or news from the conference call announcement, and the absence of such information could have contributed to the downward pressure on TFX stock.

01.07.2024 - TFX Stock was down 3.5%

• The bearish movement in TFX stock today could be attributed to profit-taking by investors after a series of positive news and earnings reports.
• Despite raising its profit forecast and surpassing earnings estimates, investors may have been expecting even better results, leading to a sell-off.
• The authorization for a significant share buyback program may have initially boosted the stock but was not enough to sustain the bullish momentum in the face of broader market pressures.
• Overall, the market reaction to TFX today seems to reflect a classic case of "buy the rumor, sell the news" behavior among investors.